DK198587D0 - Oploeselige phosphorylerede glucaner, deres fremstilling og anvendelse i laegemidler, samt fremgangsmaade til fremstilling af en cytotoksisk/cytostatisk faktor in vitro - Google Patents

Oploeselige phosphorylerede glucaner, deres fremstilling og anvendelse i laegemidler, samt fremgangsmaade til fremstilling af en cytotoksisk/cytostatisk faktor in vitro

Info

Publication number
DK198587D0
DK198587D0 DK198587A DK198587A DK198587D0 DK 198587 D0 DK198587 D0 DK 198587D0 DK 198587 A DK198587 A DK 198587A DK 198587 A DK198587 A DK 198587A DK 198587 D0 DK198587 D0 DK 198587D0
Authority
DK
Denmark
Prior art keywords
soluble
cytotoxic
vitro
phosphoriored
glucanes
Prior art date
Application number
DK198587A
Other languages
English (en)
Other versions
DK198587A (da
Inventor
Nicholas R Diluzio
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of DK198587D0 publication Critical patent/DK198587D0/da
Publication of DK198587A publication Critical patent/DK198587A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198587A 1985-08-19 1987-04-15 Oploeselige phosphorylerede glucaner, deres fremstilling og anvendelse i laegemidler, samt fremgangsmaade til fremstilling af en cytotoksisk/cytostatisk faktor in vitro DK198587A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/767,388 US4739046A (en) 1985-08-19 1985-08-19 Soluble phosphorylated glucan
PCT/US1986/001646 WO1987001037A1 (en) 1985-08-19 1986-08-13 Soluble phosphorylated glucan

Publications (2)

Publication Number Publication Date
DK198587D0 true DK198587D0 (da) 1987-04-15
DK198587A DK198587A (da) 1987-06-18

Family

ID=25079320

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198587A DK198587A (da) 1985-08-19 1987-04-15 Oploeselige phosphorylerede glucaner, deres fremstilling og anvendelse i laegemidler, samt fremgangsmaade til fremstilling af en cytotoksisk/cytostatisk faktor in vitro

Country Status (12)

Country Link
US (5) US4739046A (da)
EP (1) EP0232405B1 (da)
JP (1) JP2550332B2 (da)
KR (1) KR900008442B1 (da)
AT (1) ATE71528T1 (da)
AU (1) AU599045B2 (da)
CA (1) CA1337408C (da)
DE (1) DE3683479D1 (da)
DK (1) DK198587A (da)
FI (1) FI88109C (da)
NO (1) NO170586C (da)
WO (1) WO1987001037A1 (da)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5028703A (en) * 1988-03-11 1991-07-02 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5082936A (en) * 1984-11-28 1992-01-21 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US4900722A (en) * 1985-08-19 1990-02-13 Bioglucans, L.P. Methods and compositions for prophylactic and therapeutic treatment of infections
US4975421A (en) * 1985-08-19 1990-12-04 Bioglucan, Lp. Soluble phosphorylated glucan: methods and compositions for wound healing
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
CA1334290C (en) * 1987-02-26 1995-02-07 Adrienne Elizabeth Clarke Plant gum material and use thereof in food products
EP0295956B1 (en) * 1987-06-18 1996-09-11 Kureha Kagaku Kogyo Kabushiki Kaisha Use of a protein-bound polysaccharide for making a drug for treating AIDS.
US4904768A (en) * 1987-08-04 1990-02-27 Bristol-Myers Company Epipodophyllotoxin glucoside 4'-phosphate derivatives
HU204710B (en) * 1988-05-26 1992-02-28 Nika Health Products Inc Process for producing pharmaceutical compositions having antiviral and antibacterial effect
US5506210A (en) * 1988-08-19 1996-04-09 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
DE68926746T2 (de) * 1988-08-19 1996-11-28 Univ Australian Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel
US6747131B1 (en) 1988-10-28 2004-06-08 Pestka Biomedical Laboratories, Inc. Phosphorylated fusion proteins
IL92124A (en) 1988-10-28 1996-10-31 Sidney Pestka Recombinant proteins modified to contain post-phosphorylation that do not occur in nature
US5986061A (en) 1988-10-28 1999-11-16 Pbl Biomedical Laboratories Phosphorylated fusion proteins
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
EP0466813A4 (en) * 1989-04-05 1992-07-15 Peter Y. S Fung Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins
US4946450A (en) * 1989-04-18 1990-08-07 Biosource Genetics Corporation Glucan/collagen therapeutic eye shields
US5032401A (en) * 1989-06-15 1991-07-16 Alpha Beta Technology Glucan drug delivery system and adjuvant
FR2648350B1 (fr) * 1989-06-20 1994-07-01 Roussel Uclaf Utilisation de lipopolysaccharides extraits de bacteries gram(-) pour la fabrication d'un medicament facilitant la cicatrisation de la peau
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
WO1991003495A1 (en) * 1989-09-08 1991-03-21 Alpha Beta Technology, Inc. Method for producing soluble glucans
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
EP0491829B1 (en) * 1989-09-08 1997-06-04 Alpha Beta Technology, Inc. Composition for immune system activation
US5811542A (en) * 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
US5242806A (en) * 1990-05-07 1993-09-07 Baxter Diagnostics Inc. Method for conducting the cytotoxicity assays on tumor cells
CA2040374C (en) * 1990-07-06 1998-06-16 Gunnar Rorstad Process for enhancing the resistance of aquatic animals to disease
ES2027528A6 (es) * 1990-12-17 1992-06-01 Andromaco Lab Procedimiento para la obtencion de polimeros con actividad antiviral.
DE4101910A1 (de) * 1991-01-23 1992-07-30 Laevosan Gmbh & Co Kg Verfahren zur herstellung eines pyrogenfreien gut wasserloeslichen fructans sowie ein nierendiagnostikum, das ein solches fructan enthaelt
AU1455292A (en) * 1991-02-01 1992-09-07 Bioglucans, L.P. Soluble glucans
US5466680A (en) * 1992-03-26 1995-11-14 Cytologics, Inc. Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
AU4837693A (en) * 1992-08-05 1994-03-03 Bioglucans, L.P. Improved method for preparing soluble glucans
EP0595209A3 (en) * 1992-10-23 1996-07-17 R I T A Corp An Illinois Corp Cosmetic composition
US5919466A (en) * 1993-10-01 1999-07-06 Gerbu Biotechnik Gmbh Method for improving the yield of immunoantibodies in the vaccination of animals and humans
US5519009A (en) * 1993-10-01 1996-05-21 Donzis; Byron A. Solubilized yeast glucan
US5622940A (en) * 1994-07-14 1997-04-22 Alpha-Beta Technology Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan
JP3240102B2 (ja) 1994-08-11 2001-12-17 江崎グリコ株式会社 リン酸化糖とその製造方法
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
GB2331014C (en) * 1995-03-13 2005-06-21 Novogen Res Pty Ltd Therapeutic uses of glucan
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US5833946A (en) * 1995-06-06 1998-11-10 Bayer Corporation Dissemination of fungal infections: animal model and method of prophylaxis
US6800747B1 (en) 1995-06-07 2004-10-05 Pestka Biomedical Laboratories, Inc. Nucleic acids encoding phosphorylated fusion proteins
US6117850A (en) * 1995-08-28 2000-09-12 The Collaborative Group, Ltd. Mobilization of peripheral blood precursor cells by β(1,3)-glucan
US6083922A (en) * 1996-04-02 2000-07-04 Pathogenesis, Corp. Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
US5858378A (en) * 1996-05-02 1999-01-12 Galagen, Inc. Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen
JP2001513078A (ja) 1996-12-30 2001-08-28 バテル・メモリアル・インスティテュート 吸入により新生物を治療する製剤とその方法
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
DE19710368A1 (de) * 1997-03-13 1998-09-17 Henkel Kgaa Verwendung von wasserlöslichen beta-Glucanen als Wirkstoffe zur Herstellung von therapeutischen Mitteln zur Hautbehandlung
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
ES2245805T3 (es) * 1997-10-03 2006-01-16 Galenica Pharmaceuticals, Inc. Polisacaridos que forman iminas, preparacion de los mismos y el uso de los mismos como adyuvantes de inmunoestimulantes.
US6136794A (en) * 1998-02-02 2000-10-24 Merck & Co., Inc. Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist
US6251877B1 (en) * 1998-03-24 2001-06-26 Pacific Corporation Composition for external application containing a β-1,6-branched-β-1,3-glucan
AU760669B2 (en) 1998-04-28 2003-05-22 Galenica Pharmaceuticals, Inc. Polysaccharide-antigen conjugates
TW591105B (en) * 1998-04-30 2004-06-11 Korea Inst Sci & Tech Novel immuno-stimulating polysaccharide substance from Phellinus spp. strain and use thereof
US7030101B2 (en) 1998-09-14 2006-04-18 Nabi Biopharmaceuticals Compositions of β-glucans and specific antibodies
WO2000015238A1 (en) * 1998-09-14 2000-03-23 Nabi COMPOSITIONS OF β-GLUCANS AND SPECIFIC IGIV
US6369216B1 (en) 1998-09-25 2002-04-09 Biopolymer Engineering Pharmaceutical, Inc. Very high molecular weight β-glucans
AU6261999A (en) 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
AUPP659198A0 (en) * 1998-10-19 1998-11-12 Novogen Research Pty Ltd Mastitis treatment
US6165994A (en) * 1999-02-08 2000-12-26 Blue Ridge Pharmaceuticals, Inc. Methods for promoting the healing of cutaneous wounds and ulcers using compositions of α-D-glucans
US7101544B1 (en) 1999-07-21 2006-09-05 Kabushiki Kaisha Yakult Honsha Cholesterol-lowering agents, secondary bile acid production inhibitors, and foods and drinks
US6541678B2 (en) * 1999-09-27 2003-04-01 Brennen Medical, Inc. Immunostimulating coating for surgical devices
EP1267795A1 (en) * 2000-03-30 2003-01-02 Brennen Medical Inc. Anti-microbial and immunostimulating composition
US6713459B1 (en) 2000-04-28 2004-03-30 East Tennessee State University Methods for the prophylactic and therapeutic treatment of cardiac tissue damage
JP2001354570A (ja) * 2000-06-15 2001-12-25 Ichimaru Pharcos Co Ltd 免疫賦活剤及びそれを利用した香粧品
CZ20031262A3 (en) * 2000-10-16 2004-03-17 Neopharm, Inc. Liposomal formulation of mitoxantrone
US6436411B1 (en) * 2000-10-23 2002-08-20 The Center For The Improvement Of Human Functioning, Int'l., Inc. Cancer treatment method
AU2001218866A1 (en) * 2000-11-22 2002-06-03 D.M.G. Italia S.R.L. Preparation for strengthening the immune response in the waldeyer's ring and theoronasal mucosa by intranasal administration
US7906492B2 (en) * 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7507724B2 (en) * 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
CA2434938C (en) 2001-01-16 2012-02-28 Sloan-Kettering Institute For Cancer Research Compositions of glucan and a monoclonal antibody which exhibit an enhancement of the anti tumor activity of the antibody
WO2002081720A1 (en) * 2001-04-05 2002-10-17 Granada Bio Tech Sa De Cv Polysubstituted polycarboxylic phosphoamide biopolymers, methods for their production and uses of compositions derived therefrom
KR20100112205A (ko) * 2001-04-27 2010-10-18 아지노모토 가부시키가이샤 면역강화제
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
US20060073197A1 (en) * 2004-05-20 2006-04-06 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
US20070128253A1 (en) * 2005-04-13 2007-06-07 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
JP4561098B2 (ja) * 2001-06-01 2010-10-13 味の素株式会社 糖尿病用薬剤
AU2002320964B2 (en) * 2001-08-14 2008-03-13 Valderm Aps Treatment of hyperproliferative conditions of body surfaces
US7786094B2 (en) * 2001-10-09 2010-08-31 Biopolymer Engineering, Inc. Use of beta-glucans against biological warfare weapons and pathogens including anthrax
US7048932B2 (en) * 2002-05-22 2006-05-23 The Chinese University Of Hong Kong Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
AU2003258181A1 (en) * 2002-08-13 2004-02-25 University Of Louisville Research Foundation Inc. Methods of using beta glucan as a radioprotective agent
CA2496508C (en) 2002-09-04 2014-04-22 University Of Louisville Research Foundation, Inc. Cancer therapy using beta glucan and antibodies
US20060165700A1 (en) * 2002-09-04 2006-07-27 Ostroff Gary R Cancer therapy using whole glucan particles and antibodies
US7018986B2 (en) * 2002-09-20 2006-03-28 Immudyne Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
US20050026849A1 (en) * 2003-03-28 2005-02-03 Singh Chandra U. Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
US7197521B2 (en) * 2003-11-21 2007-03-27 Intel Corporation Method and system performing concurrently mark-sweep garbage collection invoking garbage collection thread to track and mark live objects in heap block using bit vector
KR100485056B1 (ko) * 2004-01-19 2005-04-22 (주)네추럴에프앤피 효모의 수용성 글루칸 올리고머를 함유하는 항 h1n2형 조류독감 바이러스제
BRPI0611535B1 (pt) 2005-05-05 2021-11-30 Sensient Flavors Inc Método para processar células de levedura para produzir beta-glucanos e mananas
PT1965809E (pt) 2005-11-21 2009-12-15 Bioatlantis Ltd Composições para melhorar a saúde do intestino e o rendimento animal compreendendo beta-glucanos e alfa-fucanos
US20090053221A1 (en) * 2006-01-17 2009-02-26 Cheung Nai-Kong V Immune response enhancing glucan
US8323644B2 (en) 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
FR2899815B1 (fr) * 2006-04-14 2008-07-11 Goemar Lab Sa Nouveaux medicaments pour les traitements contre les retrovirus
US20090053197A1 (en) * 2006-06-14 2009-02-26 Ramaekers Joseph C Transfer Factor Compositions and Methods
US9125874B2 (en) 2007-11-30 2015-09-08 The Ramaekers Family Trust Administration of transfer factor for improving reproductive health
US20090022799A1 (en) * 2006-10-06 2009-01-22 Shikha Pramanik Barman Compositions that contain beta-glucan to be used for the prevention and treatment of disease and methods for their use
WO2008057501A2 (en) * 2006-11-06 2008-05-15 Whitehead Institute Immunomodulating compositions and methods of use thereof
AU2009243094B2 (en) 2006-11-06 2015-02-12 Massachusetts Institute Of Technology Immunomodulating compositions and methods of use thereof
US9457047B2 (en) 2006-11-06 2016-10-04 Whitehead Institute Immunomodulating compositions and methods of use thereof
WO2009039256A1 (en) * 2007-09-18 2009-03-26 Ramaekers Nutrition, Llc Growth factor fraction compositions and methods
EP2278984A4 (en) * 2007-11-30 2013-02-27 Ramaekers Family Trust COMPOSITIONS AND METHODS FOR ENHANCING FERTILITY
US7854936B2 (en) 2008-01-14 2010-12-21 Active Organics, Inc. Anti-inflammatory hydrolysate of C. versicolor
CN101250236B (zh) * 2008-04-11 2010-09-29 武汉大学 茯苓葡聚糖磷酸酯化衍生物及其制备方法和用途
US20100267661A1 (en) * 2009-03-17 2010-10-21 Immudyne, Inc. Beta glucans and methods of use thereof
US20110129801A1 (en) * 2009-11-27 2011-06-02 Shikha Pramanik Barman Compositions and methods to prevent and treat dry socket post-operatively after tooth extraction surgery
CN107674129B (zh) * 2017-09-04 2020-12-15 珠海伊斯佳科技股份有限公司 裂褶多糖磷酸化衍生物及其制备方法、应用
WO2023002252A1 (en) 2021-07-21 2023-01-26 Bioatlantis Limited Composition comprising beta-glucans and alpha-fucans for improving gut health and animal performance and methods of making the same
US11384160B1 (en) 2021-07-30 2022-07-12 Tissue repair ltd Method of making a beta glucan compound
US11572420B1 (en) 2021-07-30 2023-02-07 Tissue repair ltd Isolated biological polysaccharide compound, methods of use and methods of manufacture thereof
CN114014949B (zh) * 2021-11-15 2022-08-30 戚春建 一种水溶性酵母葡聚糖的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1258100B (de) * 1960-11-22 1968-01-04 Wacker Chemie Gmbh Verfahren zum Phosphorylieren hydroxylgruppenhaltiger polymerer Stoffe
US3081226A (en) * 1961-01-07 1963-03-12 Luzio Nicholas R Di Process for reducing exogenous cholesterol levels in animal organisms
US3396082A (en) * 1965-06-09 1968-08-06 Agriculture Usa Glucan production by fermentation of fleshy fungi
DE1518587A1 (de) * 1965-08-23 1969-08-14 Bloecker Dr Dipl Chem Erich Verfahren zur Herstellung von Phosphorsaeureestern von hydroxylgruppenhaltigen Polymeren
US3987166A (en) * 1970-05-13 1976-10-19 Kaken Kagaku Kabushiki Kaisha Treatment of tumors with glucan compositions in mice and rats
US3943247A (en) * 1972-05-22 1976-03-09 Kaken Kagaku Kabushiki Kaisha Treatment of bacterial infections with glucan compositions
DE2646879A1 (de) * 1975-10-21 1977-05-05 Takeda Chemical Industries Ltd Matrix aus einem in wasser unloeslichen beta-1,3-glucangel und verfahren zu ihrer herstellung
US4138479A (en) * 1975-11-07 1979-02-06 Bayer Aktiengesellschaft Process for the preparation of immunopotentiating agents from components of yeast cell wall material
JPS5385000A (en) * 1976-12-31 1978-07-26 Akira Misaki Glucan and its preparation
JPS5461112A (en) * 1977-10-24 1979-05-17 Ono Pharmaceut Co Ltd Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component
FR2447193A1 (fr) * 1979-01-25 1980-08-22 Unicler Utilisation de pichia ou d'extraits de pichia, comme medicament.
EP0045338B1 (fr) * 1980-08-05 1986-11-05 LABORATOIRES DEBAT Société anonyme dite: Utilisation des glycosylglucanes en gastroentérologie dans le traitement des colopathies
US4340673A (en) * 1980-11-07 1982-07-20 Merck & Co., Inc. Process of producing modified glucans as anti-caries agent
US4614733A (en) * 1981-12-31 1986-09-30 Kureha Kagaku Kogyo Kabushiki Kaisha Polysaccharides pharmaceutical compositions and the use thereof
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan

Also Published As

Publication number Publication date
US4877777A (en) 1989-10-31
FI88109B (fi) 1992-12-31
FI871718A0 (fi) 1987-04-16
US4761402A (en) 1988-08-02
JP2550332B2 (ja) 1996-11-06
FI871718A (fi) 1987-04-16
DE3683479D1 (de) 1992-02-27
WO1987001037A1 (en) 1987-02-26
DK198587A (da) 1987-06-18
EP0232405B1 (en) 1992-01-15
US4833131A (en) 1989-05-23
CA1337408C (en) 1995-10-24
EP0232405A4 (en) 1989-04-27
ATE71528T1 (de) 1992-02-15
FI88109C (fi) 1993-04-13
US4739046A (en) 1988-04-19
NO170586C (no) 1992-11-04
JPS63500805A (ja) 1988-03-24
NO871603L (no) 1987-06-15
US4818752A (en) 1989-04-04
AU6229686A (en) 1987-03-10
AU599045B2 (en) 1990-07-12
EP0232405A1 (en) 1987-08-19
NO871603D0 (no) 1987-04-15
KR900008442B1 (ko) 1990-11-22
KR870700355A (ko) 1987-12-28
NO170586B (no) 1992-07-27

Similar Documents

Publication Publication Date Title
DK198587A (da) Oploeselige phosphorylerede glucaner, deres fremstilling og anvendelse i laegemidler, samt fremgangsmaade til fremstilling af en cytotoksisk/cytostatisk faktor in vitro
ES2069582T3 (es) Nucleosidos terapeuticos.
CA2033044A1 (en) 6-substituted purine carbocyclic nucleosides
UA34419C2 (uk) Ліофілізований препарат для ін'єкцій та спосіб інгібування росту пухлин
IE38602B1 (en) Aryloxyalnolamine derivatives their preparation and use in pharmaceutical compositions
EP0293826A3 (en) Therapeutic and prophylactic application of sulfated polysaccharides against aids
NO920395D0 (no) Terapeutisk aktive benzyloksyfenyl-derivater og fremgangsmaate for deres fremstilling
IE35177B1 (en) Improvements in or relating to uracil derivatives
ATE79035T1 (de) Calcium- und magnesiumkomplexe von phytohaemagglutinin-polyheteroglykanen, ihre herstellung und pharmazeutische zubereitungen.
EP0217372A3 (en) Polyoxygenated labdane derivatives, process for their preparation and their use as medicaments
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
IT1106073B (it) Procedimento per la produzione di polisaccardi per estrazione dai corpi microbici dello haemophilus in fluenza e prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo
ES451058A1 (es) Un procedimiento de preparacion de un nuevo derivado de oxa-zol.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
EP0132359A3 (en) Natural human interleukin-2 and production thereof
CA2255856A1 (en) Therapeutic uses for an aminosterol compound
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
EP0161384A3 (en) Human endogenous cancer regulatory factors, method of preparing the same, and pharmaceutical compositions containing the same
EP0250192A3 (en) Therapeutic compositions
GR1002969B (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε αιωρημα εμβρυικων κυτταρων με δραση ανοσοποιητικης υποκαταστασης και μεθοδος θεραπειας του συνδρομου της επικτητης μολυνσης ανοσοποιητικης ανεπαρκειας (hiv) με τη χρηση αυτου του παρασκευασματος.
Majchrowicz Kombucha: a dubious" cure"
WO2023169554A8 (zh) 甲硫氨酸腺苷转移酶抑制剂、其制备方法及应用
IE38289L (en) Bis [azapolycycloalkylalkoxy] fluorenes.
IT7829926A0 (it) Riduzioni delle perdite frontali nei pannelli solari piani o ad altre forme.
UA31379A (uk) Спосіб лікування ішемічної хвороби серця

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment